Utility of telemedicine in COVID-19 pandemic: our experience at a tertiary cancer center in North East India

Ashok Kumar Das, Sumanjit S. Boro, Anupam Das, Partha Pratim Medhi, Kaberi Kakati, Nizara Baishya, Mouchumee Bhattacharyya, Amal Chandra Kataki


Background: Telemedicine is a very useful tool of communication between the doctor and the patient. The aim of this study was to find out the utility of telemedicine during the lockdown period of COVID-19 pandemic in North East India.

Methods: It is a cross sectional study among the cancer patients at our center on follow up or ongoing treatment and analysis of all the data acquired from telephonic conversation with our patients from 30th March, 2020 to 3rd May, 2020. Have contacted 4181 patients during this period over phone. All phone calls were done by respective department doctors.

Results: From the demographic data, we get that 35.4% of patients were at good physical condition, 3.5% with poor general condition, 11.6% patients having ongoing treatment in our institute, 21.1% patients expired, 0.9% patients have nonmalignant diagnosis, 1.4% patients left the institute due to various reasons. Analyzed this data with brain storming sessions amongst the COVID-19 task force doctors and tried to find out solutions of each problem.

Conclusions: Telemedicine cannot replace conventional method of in person treatment, but it proved to be a useful tool during the COVID-19 pandemic for patient follow up and treatment of cancer patients.


COVID-19, Telemedicine, Cancer

Full Text:



Strehle EM, Shabde N. One hundred years of telemedicine: does this new technology have a place in paediatrics? Arch Disease Childhood. 2006;91(12):956-59.

WHO. A health telematics policy in support of WHO’s Health-For-All strategy for global health development: report of the WHO group consultation on health telematics, 11-16 December, Geneva, 1997. Geneva, World Health Organization, 1998. Available at: Accessed on 12th August 2020.

Telemedicine Practice Guidelines- MoHFW. Available at: Accessed on 2020 October 13.

Associated Press. Doctor-patient ratio in India less than WHO-prescribed norm of 1:1000: Govt. The Economic Times. 2019 Nov 20. Available at: Accessed on 2020 October 13.

WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19; 11 March, 2020. Available at: https:// Accessed on 2020 October 13.

Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA 2020;323(15):1499-1500.

Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10:589-97.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al. Cancer patients in SARS-CoV-2 infection: a nationwide analy-sis in China. Lancet Oncol. 2020;21(3):335-7.

Lambertini M, Toss A, Passaro A, Criscitiello C, Cremolini C, Cardone C et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective. ESMO Open. 2020;5: e000759.

Smrke A, Younger E, Wilson R, Husson O, Farag S, Merry E et al. Telemedicine during the COVID-19 pandemic: Im-pact on care for rare cancers. JCO GO. 2020;6:1046-51.

Moazzami B, Khorasani NR, Moghadam AD, Farokhi E, Rezaei N. COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers wellbeing. J Clin Virol. 2020;126:104345.